Jennifer B. Levin, PhD

Medication adherence is often difficult in bipolar patients. This trial combined a behavioral customized adherence enhancement approach with long-acting injectable antipsychotics and assessed effects on adherence, symptoms, and functional...

Treatment nonadherence is bipolar disorder ranges from 20% to 60%. Read this article to learn how customized adherence enhancement (CAE)—a brief, bipolar disorder-specific approach that targets individual adherence barriers—compared...